Stay updated on Nebulized Fentanyl in ILD Patients Clinical Trial
Sign up to get notified when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.

Latest updates to the Nebulized Fentanyl in ILD Patients Clinical Trial page
- CheckyesterdayChange DetectedThe footer now displays ClinicalTrials.gov revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study record for nebulized fentanyl in people with interstitial lung disease is displayed, including its study design, eligibility criteria, interventions, outcomes, locations, and record dates.SummaryDifference42%

- Check22 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA site-wide NIH announcement banner describes a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check36 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check43 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0. The page remains a 403 error page.SummaryDifference0.2%

Stay in the know with updates to Nebulized Fentanyl in ILD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nebulized Fentanyl in ILD Patients Clinical Trial page.